By: Sara Riascos  May. 31, 2022
Myocardial Infarctions are frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Clopidogrel is a blood thinner used to prevent stroke, heart attack, and other heart problem. Studies have shown that clopidogrel could reduce all-cause mortality and the probability of recurrent myocardial infarctions.
Read moreBy: Sara Riascos  May. 30, 2022
Myocardial Infarctions are frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Clopidogrel is a blood thinner used to it can prevent stroke, heart attack, and other heart problems. Studies have shown that clopidogrel could reduce all-cause mortality and the probability of recurrent myocardial infarctions.
Read moreBy: Sara Riascos  May. 26, 2022
Myocardial Infarctions are frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing.Clopidogrel is a blood thinner used to prevent stroke, heart attack, and other heart problems. Studies have shown that clopidogrel could reduce all-cause mortality and the probability of recurrent myocardial infarctions.
Read more